Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Midsona, Audiocast with teleconference, Q3'24

By Inderes10/23/2024, 9:00 AM
Midsona

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Peter Osbourne
00:00 - 13:39

Thank you so much for attending this call. This is Peter Osbourne speaking, CEO of Midsona. As a top line summary, I would conclude that we took a step forward. Also, in the third quarter, we delivered organic sales growth for the second consecutive quarter. We significantly strengthen our margins and also our operating results. That said, we are on a journey, and the steps taken so far are really only the first steps in our long-term quest to reach our financial targets. And before we delve into the numbers, I would just like to make you aware that there might be certain forward-looking statements in this presentation and that such statements are subject to risk and uncertainty. So let's dive into quarter three. I would say that overall we are reasonably happy with our progress in the quarter. Sales were slightly down due to currency effects, but we're still posting an organic sales growth of just below 3%. Looking at EBIT, before one-off items, we improved to 32 million, which should be compared to 18 million last year. Absolute EBIT increased from 9 million last year to 32 million Swedish kronor this year. So quite a good improvement. And if we look at the key components or ingredients of that, of course we're helped by the organic sales. We have good management of our product mix and also quite effective cost control. One of the key items is, of course, the gross margin. And we saw a good increase from 25.2% last year to 25.28% this year. And this is before items affecting comparability. And this was despite continued high raw material prices. Despite this, we have continued our complexity reduction project. What we are doing is relentlessly stopping low-margin products. We are keenly focused on discontinuing both low-profit product lines and private label and foodservice options, thereby considerably improving our margin profile. It's also worth noting that our leverage has come down significantly. Net debt in relation to EBITDA was at two times in quarter three, and that should be compared to four times last year. So we have effectively halved our leverage in one year. And this, to me and hopefully to you, clearly signals that we are a financially much more solid company. Clearly signals that we are financially a much more solid company. So as a key conclusion, I would say that we are taking steps forward also in quarter three. But still, there is a lot to improve. Let's dive into our different categories or segments. We did see slight organic growth; the organic category grew by 2%. I would say that market conditions are still somewhat challenging. And generally speaking, we see some stabilization in certain markets, but also some markets and channels are still quite depressed. So in that light, I think that we should be quite satisfied with an organic growth of 2%. Our expectation is that the market will gradually improve as we see lower inflation and interest rates coming down, and we think that this will restore consumer confidence and spending also in the organic category. I would also state that our market intelligence clearly shows that consumers want to spend on healthy and sustainable products, but they have been somewhat restrained by the economic downturn in the last couple of years. But as economic conditions improve, we think that market conditions for organic will also improve. And one of the brands that grew nicely was Davert in Germany. It was held by completely new customers, as well as new listings, that helped older customers. Helios continued to grow nicely in Norway, while we saw slight declines in the market as the market condition for organic foods was still somewhat restrained in both Sweden and Denmark. Private Label continues to be a major driver in the organic segment. Demand was very high, but we also faced some production constraints, especially in our German factories. And had it not been for those, sales could have been even higher. If we look at our conventional health food brands, we saw a decline, and this was completely due to us stepping out of some less profitable private label contracts and brand campaigns. On the positive side, Friggs continued to grow in the consumer health category. We saw very strong growth, 20% organic growth, and this was driven by a new distribution contract in Finland, but also very good performance for some of our key brands. Let's go into the divisions. All three divisions improved operating profit compared to last year. But it should be said that it's really the Nordic division which is the shining star. Um, it's flat sales, actually, as we continue to terminate some unprofitable contracts. But also, as mentioned before, we had weak market conditions for organic foods. Friggs continued to perform very well. Helios developed very nicely in Norway. Helios developed very nicely in Norway, and we did see good development for many of our consumer health brands in the Nordic region as well. So while we saw some ups and downs in sales, EBIT saw very strong development. We are selling a more profitable mix, as we have put more emphasis on our brands while simultaneously exiting low profitability private label contracts. Private label contracts and EBIT improved a very nice 35% to 66 million in the quarter. The North Division sales increased by 3%. And this was despite some supply challenges that we are putting a lot of effort into fixing now. We have installed extra shifts and are also working on production efficiency to better meet the expected high demand, not only in quarter four but also going forward in Germany. I would say that in Division North, the third quarter is a bit of a low season. We posted a loss of 3 million SEK in EBIT. It's better than the negative 7 million last year. But of course, it's not at a satisfactory level. We love them, so we will continue to work on strongly improving performance in Division Ascheberg. Also, in the division itself, we experience a bit of a low season in the third quarter; however, I would say that it's still an issue since a deficit of eight million is, of course, very significant and unacceptably low. We have initiated several projects aimed both at improving operations and boosting sales within the region. Gross margin and gross margin management are the key drivers behind our improved profit. And here is, of course, good to see that we are doing well in all three divisions, and it's pretty much the same factors in all the divisions that contribute to the better gross margin. It's efficient price management. We are step by step improving production efficiency, but it is still a long way to go. To be as effective as we want. We are substituting low-margin Private Label contracts with better-margin ones. We do discontinue low-margin full-service contracts, and we also focus some licensing agreements on our brands with higher margins. And it should also be said that in this mix, we have robust, stable raw material prices. We continue to drive innovation. This is very important for us in order to drive net sales and achieve organic growth. I will just show two quick examples. One is the new innovative spreads that we have launched under the brand name Davert in Germany. And we say that, generally speaking, we do see very high demand for our spreads. And we have recently expanded our production in this segment. Another example, which you can find on the next page, is Gainomax, the sports nutrition brand. And we have recently added three new tasty bars with a healthier profile, solid content, and no added sugar. For those of you following us, you have seen this before. Our strategy that was presented in the spring. It's really focused on increasing our profitability and strengthening our market position for the future. And we have three main pillars to do this. One is what we call an organic powerhouse. It's about strengthening our organic portfolio. Then we have the strategy to grow and expand our health brands, brands like Friggs and Gainomax that I've talked about earlier in the presentation. And last but not least, to really step-change our internal efficiency and harmonization by driving efficiency across the total value chain, from sourcing to production. At the same time as we updated our strategy, we also updated our financial targets. So this was done in spring. It's our aim to reach an organic sales growth of 3 to 5% per year. As I said earlier, we are posting the second quarter in a row with organic sales growth. It was 2.6%. We're still not up at the level where we want to be, but step by step, we should get there with a bit of 8%. And this we should achieve by 2027. Still, of course, there's quite some way to go. And this is really one of our main focus areas to step by step drive towards that target. We do take a decent step forward from 2% in quarter three, 2023 to 3.5% in quarter three this year. And last but not least, a gearing of net debt versus EBITDA of maximum 2.5 times. We are already below this, and as I said, this signals that we are now much more financially stable and can therefore be more aggressive in the future. Before I hand over to CFO Max Bokander, I would just like to give a brief summary. Our third quarter earnings show that we are on the right track. We can see that the continuous streamlining and coordination of the product range has had a clear impact on earnings, and we are continuing to work to create conditions for organic growth. And indeed, we achieved organic growth for the second quarter in a row. Now in quarter three. The focus for the rest of 2024 and the upcoming year is, of course, to continue with the implementation of the strategy. 2025 is, of course, to continue with the implementation of the strategy. We are happy about the progress so far, but far from satisfied. It is our ambition now to step by step move towards our financial targets. Max, please. Thank you, Peter. I will start with a short financial summary for the quarter, and the net sales declined by 0.4%, but clean from currency and structural effects, the sales grew by 2.6%. The gross margin continued to improve by 2.3 percentage points, and the EBIT increased by 77% compared to last year. The net result improved.

Max Bokander
13:39 - 16:53

27 million, i.e. This amounted to $30 million more than the EBIT improvement. This was driven by lower financing costs and the fact that last year included $9 million of restructuring costs. The cash flow from operating activities landed at $42 million, which was $45 million weaker than last year. Fully explained by a change in working capital, the net debt to EBITDA ratio also continued to improve and landed at 2.0. Looking at the net sales development for the quarter, the organic growth, as mentioned, landed at 2.6%, even accounting for one additional invoicing day. The quarter showed organic growth. Looking at the sales by brand type for our own brands, some continue to struggle on markets where we still have a higher demand for products in the lower price range. You can also see that our Private Label business, focusing more on lower price segments, grew by 6.6% during the quarter. Here, both South and North Europe continue to show very strong growth. While we in the Nordics still experienced slight negative growth due to the termination of low-margin contracts. The licensed brand also grew strongly, but it's a smaller part of our business. It grew by 19.2%, driven by the increased scope of an existing distribution agreement on the Finnish market. Now explaining the EBIT development compared to last year. The organic sales growth, or in this case labeled as volume, resulted in a 5 million higher contribution. The improved gross margin, which resulted from better price management and higher margins on private label contracts, generated a 20 million higher contribution. The sales and admin expenses, however, increased by about 5 million, mainly driven by higher investment in selling activities. As a summary, EBIT landed at 32 million for the quarter, which was an increase of 77% compared to last year. Moving over to the cash flow. As already mentioned, it landed on 42 million and the cash flow was negatively impacted by a periodic increase in working capital of 23 million, driven by the seasonal build-up of inventory for quarter four. Finally, from the slide, our cash and debt situation, we ended the quarter with $575 million in available cash, which represents 15% of our last 12 months' net sales. And as already mentioned, the net debt in relation to EBITDA continued to improve and landed at 2.0, which is 0.5 times better than our financial target. With this final slide, I would like to hand back to the operator and open up for questions.

Operator
17:00 - 17:26

If you wish to ask a question, please dial Pound Key five on your telephone keypad. To enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from Nicola Kalinowski from ABG Sundal Collier. Please go ahead.

Unknown 1
17:27 - 17:27

Yes.

Unknown 2
17:27 - 17:45

Petromax, and thanks for the presentation. Um, just one quick question to begin with. Could you perhaps give us a brief update on how you're progressing with the reduction of the SKUs and, perhaps more importantly, how much work you have left to do in this area?

Peter Osbourne
17:47 - 18:44

I mean, as we have discussed in previous calls, this is an ongoing process. I would say that we are more than halfway by now, but it is definitely an ongoing process. And what it has shown is that while it has resulted in somewhat lower net sales in certain categories, it has really improved our margin profile. So this is something that we want to continue. Um, as we have mentioned also in previous calls, we are in the process of setting up a more centralized purchasing organization, and we're about to hire a chief purchasing director in the near future. And by that, we think that this process will continue well into 2025. So we are doing this step by step now. And the key focus is to improve our margin profile, while of course, at the same time, delivering on our organic growth target.

Unknown 2
18:47 - 19:16

Yes, that sounds very healthy indeed. I fully understand. And then, second question, you wrote in the report a couple of comments on the implementation of the new organization, through which you're introducing new central marketing and innovation, purchasing, and HR functions. Is there any chance that you could clarify this? Does this mean that your opex base is higher now going forward because of new hires, or is it merely an organizational adjustment, if you know what I mean?

Peter Osbourne
19:18 - 19:49

I would say that it's more of an organizational adjustment. So we're essentially streamlining the organization to have a slightly stronger headquarters, but then also fewer resources in the divisions. So it's not something that should drive major opex costs. We have a few exceptions. We did hire a sourcing director, a position we did not have in the company before. But overall, tighter control will continue to be very important to us.

Unknown 2
19:53 - 20:21

Very clear. Thanks. And finally, you appear to tie up a little less working capital than some peers and less than I had anticipated. Uh, and that's subjective to a degree. But would you say that this relatively lower capital tie-up is related to a discontinuation of SKUs that have been a negative drag on working capital, or have you become more efficient in some way as well?

Max Bokander
20:23 - 21:43

Um, yes. Uh. You're right. It's an effect of the complexity reduction as well. We are more efficient. I mean, we do not only consider the profitability of the product but also perform a return on capital employed analysis. So many of. Unfortunately, many of the low-margin contracts that we have discontinued also tied up capital historically. But this then means that we should not need to build the same level of inventory in the same level of growth going forward. So yes, it's true. Um, I do, I mean, if you look at the absolute value of working capital, we are now coming to the level where we were almost last year at the same time. And I do, of course, not expect us to have the same cash flow effect in quarter four. Due to that and maybe actually with the remark we made last year when we presented quarter four, where we came in lower than anticipated and planned, we may have a lesser release in quarter four due to that.

Unknown 2
21:45 - 21:50

Yep. Super clear answer. Thank you very much, Max. I think that's all for me and well done.

Unknown 1
21:50 - 21:51

Thank you.

Operator
21:57 - 22:17

As a reminder, if you wish to ask a question, please dial pound key five on your telephone keypad. There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.

Peter Osbourne
22:19 - 22:38

Well, Peter here then. I would just like to thank you for your attendance and we are on a journey. We are taking steps forward. We will continue to drive forward towards our financial targets, and I'm happy to talk to you again after next quarter. Thank you so much.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…